PL2501361T3 - Sposób leczenia chorób siatkówki przy użyciu tamponady wewnątrzgałkowej - Google Patents
Sposób leczenia chorób siatkówki przy użyciu tamponady wewnątrzgałkowejInfo
- Publication number
- PL2501361T3 PL2501361T3 PL10781890T PL10781890T PL2501361T3 PL 2501361 T3 PL2501361 T3 PL 2501361T3 PL 10781890 T PL10781890 T PL 10781890T PL 10781890 T PL10781890 T PL 10781890T PL 2501361 T3 PL2501361 T3 PL 2501361T3
- Authority
- PL
- Poland
- Prior art keywords
- treating retinal
- retinal conditions
- intraocular tamponade
- tamponade
- intraocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26271909P | 2009-11-19 | 2009-11-19 | |
| EP10164362.5A EP2394636B1 (en) | 2010-05-28 | 2010-05-28 | Method for treating retinal conditions using an intraocular tamponade |
| PCT/EP2010/067844 WO2011061297A1 (en) | 2009-11-19 | 2010-11-19 | Method for treating retinal conditions using an intraocular tamponade |
| EP10781890.8A EP2501361B1 (en) | 2009-11-19 | 2010-11-19 | Method for treating retinal conditions using an intraocular tamponade |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2501361T3 true PL2501361T3 (pl) | 2015-08-31 |
Family
ID=42537654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10781890T PL2501361T3 (pl) | 2009-11-19 | 2010-11-19 | Sposób leczenia chorób siatkówki przy użyciu tamponady wewnątrzgałkowej |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US9616016B2 (pl) |
| EP (2) | EP2394636B1 (pl) |
| JP (1) | JP5712221B2 (pl) |
| KR (1) | KR101785629B1 (pl) |
| CN (1) | CN102630158B (pl) |
| AU (1) | AU2010320869B2 (pl) |
| BR (1) | BR112012011825B1 (pl) |
| CA (1) | CA2781027A1 (pl) |
| DK (1) | DK2501361T3 (pl) |
| EA (1) | EA026789B1 (pl) |
| ES (1) | ES2538251T3 (pl) |
| GE (1) | GEP20146139B (pl) |
| HU (1) | HUE025304T2 (pl) |
| MX (1) | MX2012005815A (pl) |
| MY (1) | MY159167A (pl) |
| NZ (1) | NZ599992A (pl) |
| PH (1) | PH12012500967A1 (pl) |
| PL (1) | PL2501361T3 (pl) |
| PT (1) | PT2501361E (pl) |
| UA (1) | UA109642C2 (pl) |
| WO (1) | WO2011061297A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
| RU2548814C2 (ru) * | 2013-08-02 | 2015-04-20 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ микроинвазивного хирургического лечения рецидива отслойки сетчатки в нижнем сегменте с применением ретинотомии и повторной тампонады витреальной полости |
| GB201522441D0 (en) * | 2015-12-18 | 2016-02-03 | Midatech Pharma Wales Ltd | Sustained release cyclosporine-loaded microparticles |
| RU2644712C1 (ru) * | 2017-04-20 | 2018-02-13 | Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ хирургического лечения сквозных макулярных разрывов большого диаметра с применением контрастирующей суспензии "Витреоконтраст" |
| RU2675463C1 (ru) * | 2017-11-09 | 2018-12-19 | Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" | Способ хирургического лечения пациентов с пролиферативной витреоретинопатией на фоне сахарного диабета |
| EP4218671A1 (en) | 2018-07-19 | 2023-08-02 | Sanulus Medical, LLC | Devices and methods for targeted delivery of a substance |
| US12089893B2 (en) | 2018-07-19 | 2024-09-17 | Sanulus Medical, LLC | Devices and methods for targeted delivery of a substance |
| WO2020077106A1 (en) * | 2018-10-11 | 2020-04-16 | Imbria Pharmaceuticals, Inc. | Compositions and methods for treating and preventing leber's hereditary optic neuropathy |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE442820B (sv) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut |
| JPH0636816B2 (ja) * | 1985-07-04 | 1994-05-18 | 株式会社ミドリ十字 | 眼疾患治療補助剤 |
| DE4211958A1 (de) * | 1992-04-01 | 1993-10-21 | Pharmpur Gmbh | Behandlungsmittel für die Augenheilkunde und seine Verwendung |
| ES2094688B1 (es) * | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
| EP1027016A4 (en) | 1997-10-27 | 2006-03-08 | Univ California | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REFERRING RETINAL RIPPLE |
| WO2001097832A1 (de) * | 2000-06-21 | 2001-12-27 | Audit Institute For Medical Services And Quality Assurance Gmbh | Pharmazeutische zubereitungen enthaltend cyclosporine und neutralöle |
| FR2823441B1 (fr) * | 2001-04-12 | 2004-09-10 | Thea Lab | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation |
| ES2295397T3 (es) * | 2001-04-18 | 2008-04-16 | Prometic Biosciences Inc. | Acidos grasos como factores de supervivencia y activacion de neutrofilos. |
| JP2004043337A (ja) * | 2002-07-10 | 2004-02-12 | Nisshin Oillio Ltd | 血中中性脂肪濃度調整剤 |
| US6703378B1 (en) | 2002-09-19 | 2004-03-09 | Bausch & Lomb Incorporated | Vitreoretinal tamponades based on fluorosilicone fluids |
| US20050244469A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
| US7659260B2 (en) | 2005-01-14 | 2010-02-09 | Eddie Francis Kadrmas | Tamponade compositions and methods for retinal repair |
| US8492400B2 (en) * | 2006-02-09 | 2013-07-23 | Santen Pharmaceutical Co., Ltd. | Stable formulations, and methods of their preparation and use |
| US20070218007A1 (en) * | 2006-03-17 | 2007-09-20 | Allergan, Inc. | Ophthalmic visualization compositions and methods of using same |
| EP2129364B1 (en) * | 2006-12-21 | 2020-04-15 | Santen SAS | Process for manufacturing ophthalmic oil-in-water emulsions |
| CN101062040B (zh) * | 2007-05-31 | 2011-11-16 | 沈阳药科大学 | 稳定型葫芦素液体组方及其制剂 |
| FI20075662A0 (fi) | 2007-09-21 | 2007-09-21 | Licentia Oy | Intraokulaarinen siirre |
| KR20100067684A (ko) * | 2007-11-05 | 2010-06-21 | 보오슈 앤드 롬 인코포레이팃드 | 약물 전달을 위한 비히클로서의 수불혼화성 물질 |
| EP2394636B1 (en) * | 2010-05-28 | 2014-03-19 | Novagali Pharma S.A. | Method for treating retinal conditions using an intraocular tamponade |
-
2010
- 2010-05-28 EP EP10164362.5A patent/EP2394636B1/en not_active Withdrawn - After Issue
- 2010-11-19 WO PCT/EP2010/067844 patent/WO2011061297A1/en not_active Ceased
- 2010-11-19 HU HUE10781890A patent/HUE025304T2/en unknown
- 2010-11-19 US US12/950,063 patent/US9616016B2/en active Active
- 2010-11-19 CN CN201080052481.0A patent/CN102630158B/zh active Active
- 2010-11-19 BR BR112012011825-0A patent/BR112012011825B1/pt active IP Right Grant
- 2010-11-19 US US13/510,872 patent/US20120238536A1/en not_active Abandoned
- 2010-11-19 MX MX2012005815A patent/MX2012005815A/es active IP Right Grant
- 2010-11-19 NZ NZ599992A patent/NZ599992A/en not_active IP Right Cessation
- 2010-11-19 UA UAA201206133A patent/UA109642C2/ru unknown
- 2010-11-19 PL PL10781890T patent/PL2501361T3/pl unknown
- 2010-11-19 MY MYPI2012002202A patent/MY159167A/en unknown
- 2010-11-19 EP EP10781890.8A patent/EP2501361B1/en active Active
- 2010-11-19 PH PH1/2012/500967A patent/PH12012500967A1/en unknown
- 2010-11-19 EA EA201200761A patent/EA026789B1/ru not_active IP Right Cessation
- 2010-11-19 KR KR1020127013233A patent/KR101785629B1/ko active Active
- 2010-11-19 GE GEAP201012712A patent/GEP20146139B/en unknown
- 2010-11-19 ES ES10781890.8T patent/ES2538251T3/es active Active
- 2010-11-19 CA CA2781027A patent/CA2781027A1/en not_active Abandoned
- 2010-11-19 PT PT107818908T patent/PT2501361E/pt unknown
- 2010-11-19 JP JP2012539339A patent/JP5712221B2/ja active Active
- 2010-11-19 DK DK10781890.8T patent/DK2501361T3/da active
- 2010-11-19 AU AU2010320869A patent/AU2010320869B2/en active Active
-
2017
- 2017-02-23 US US15/440,899 patent/US20170165368A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL212986A0 (en) | Methods for treating eye disorders | |
| EP2760359A4 (en) | METHOD FOR TREATING EYE STATES | |
| EP2753275A4 (en) | METHODS OF TREATING OCULAR CONDITIONS | |
| PL2821405T3 (pl) | Estry cholinowe do leczenia prezbiopii i zaćmy | |
| IL231631B (en) | A preparation for the treatment of an eye condition containing presbyopia | |
| EP2755547A4 (en) | SYSTEM AND METHOD FOR ASSESSING THE NETWORK SKIN FUNCTION | |
| PT2506830T (pt) | Emulsão oftálmica | |
| KG1376C1 (en) | Method for keratoconus treatment | |
| EP2598936A4 (en) | METHOD FOR PRODUCING UV LIGHT ABSORBENT GLASSES | |
| EP2582374A4 (en) | METHOD FOR TREATING NERVOUS ELEMENTS | |
| PL2667877T3 (pl) | Kompozycja androgenu do leczenia stanu okulistycznego | |
| IL229192A0 (en) | A method for treating vision disorders | |
| PT2403503T (pt) | Métodos para tratar doenças inflamatórias oculares | |
| PT2501361E (pt) | Processo para o tratamento de condições da retina utilizando um tamponamento intraocular | |
| ZA201208219B (en) | Method for treating wasterwater | |
| EP2558104A4 (en) | METHOD AND OPHTHALMIC COMPOSITION FOR TREATING RETINAL DISEASE | |
| ZA201403430B (en) | 4-pregenen- 11ss -17 - 21-triols-3, 20- dione derivatives for the treatment of ocular conditions | |
| IL217492A0 (en) | Treatment method | |
| ZA201401954B (en) | A composition and method for treating an autoimmune disease | |
| EP2391385A4 (en) | METHODS OF REGENERATING PANCREATIC TISSUE | |
| SG10201401310VA (en) | Method for treating immune disorders | |
| ZA201200124B (en) | Method of treating age related disorders | |
| EP2763559A4 (en) | NON-INVASIVE SYSTEM AND METHOD FOR ATTENUATING LOADS ASSOCIATED WITH A SLEEP POSITION | |
| HK1175405A (en) | Method for treating retinal conditions using an intraocular tamponade | |
| HK1184049A (en) | Methods for treating neurological conditions |